ArticleCellular oncology (Dordrecht, Netherlands)2023

RRM2 as a novel prognostic and therapeutic target of NF1-associated MPNST.

Man-Hon Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.